Parthenolide as an Experimental Antifibrotic Agent: Mechanistic Insights and Therapeutic Prospects in Renal Fibrosis. CDF [Internet]. 2024 Nov. 20 [cited 2026 Aug. 17];53(03):6582-9. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/3876